PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för 1-hydroxymidazolam beta-D-glucuronide. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

10 hits

Bibliografisk träff 2012-08-01

Critical illness is a major determinant of midazolam clearance in children aged 1 month to 17 years.

Ince I, de Wildt SN, Peeters MY, Murry DJ, Tibboel D, Danhof M, Knibbe CA.

Ther Drug Monit · research support, non-u.s. gov't; journal article · DOI 10.1097/ftd.0b013e31825a4c3a

Bibliografisk träff 2010-08-16

Metabolism of 1'- and 4-hydroxymidazolam by glucuronide conjugation is largely mediated by UDP-glucuronosyltransferases 1A4, 2B4, and 2B7.

Seo KA, Bae SK, Choi YK, Choi CS, Liu KH, Shin JG.

Drug Metab Dispos · research support, non-u.s. gov't; journal article · DOI 10.1124/dmd.110.035295

Bibliografisk träff 2008-04-11

Pharmacokinetics of intravenous and oral midazolam in plasma and saliva in humans: usefulness of saliva as matrix for CYP3A phenotyping.

Link B, Haschke M, Grignaschi N, Bodmer M, Aschmann YZ, Wenk M, Krähenbühl S.

Br J Clin Pharmacol · comparative study; research support, non-u.s. gov't; research-article; clinical trial, phase i; randomized controlled trial; journal article · DOI 10.1111/j.1365-2125.2008.03201.x

Bibliografisk träff 2008-02-06

Contribution of the N-glucuronidation pathway to the overall in vitro metabolic clearance of midazolam in humans.

Klieber S, Hugla S, Ngo R, Arabeyre-Fabre C, Meunier V, Sadoun F, Fedeli O, Rival M, Bourrie M, Guillou F, Maurel P, Fabre G.

Drug Metab Dispos · journal article · DOI 10.1124/dmd.107.019539

Bibliografisk träff 2007-11-12

Characterization of 1'-hydroxymidazolam glucuronidation in human liver microsomes.

Zhu B, Bush D, Doss GA, Vincent S, Franklin RB, Xu S.

Drug Metab Dispos · journal article · DOI 10.1124/dmd.107.017962

Bibliografisk träff 2003-09-01

Possibility of influence of midazolam sedation on the diagnosis of brain death: concentrations of active metabolites after cessation of midazolam.

Hirata K, Matsumoto Y, Kurokawa A, Onda M, Shimizu M, Fukuoka M, Hirano M, Yamamoto Y.

Yakugaku Zasshi · journal article · DOI 10.1248/yakushi.123.811

Bibliografisk träff 1999-10-01

Effects of chronic administration of glucocorticoid on midazolam pharmacokinetics in humans.

Nakajima M, Suzuki T, Sasaki T, Yokoi T, Hosoyamada A, Yamamoto T, Kuroiwa Y.

Ther Drug Monit · clinical trial; journal article · DOI 10.1097/00007691-199910000-00003

Bibliografisk träff 1991-01-01

The effects of acute changes in renal function on the pharmacokinetics of midazolam during long-term infusion in ICU patients.

Driessen JJ, Vree TB, Guelen PJ.

Acta Anaesthesiol Belg · journal article

Bibliografisk träff 1989-11-01

Decreased plasma albumin concentration results in increased volume of distribution and decreased elimination of midazolam in intensive care patients.

Vree TB, Shimoda M, Driessen JJ, Guelen PJ, Janssen TJ, Termond EF, van Dalen R, Hafkenscheid JC, Dirksen MS.

Clin Pharmacol Ther · journal article · DOI 10.1038/clpt.1989.182

Bibliografisk träff 1984-01-01

Placental transfer of midazolam and its metabolite 1-hydroxymethylmidazolam in the pregnant ewe.

Vree TB, Reekers-Ketting JJ, Fragen RJ, Arts TH.

Anesth Analg · journal article · DOI 10.1213/00000539-198401000-00006